Please wait while the transcript is being prepared...
0:00
Good day and welcome.
I'm Jerry Sebag, Professor
of Clinical Ophthalmology
at the Doheny Eye Institute,
and Founding Director
of the VMR Institute
for Vitreous Macula
and Retina
in Southern California.
The topic of my lecture
is vitreous,
which has been a subject
of great interest to me
for almost four decades.
A great deal has been learned
about vitreous
during this time
and it's my pleasure share
some of the most
recent information with you
and hopefully stimulate
your interest.
0:36
There has been a growth
of knowledge in vitreous
as I alluded to,
beginning back in 1930
when Sir Stewart Duke-Elder
published a monograph
on vitreous
that was primarily scientific,
had very little
clinical information.
The monograph was 72 pages long.
The next major publication
on vitreous was in 1989,
also a monograph,
and that book was 173 pages,
containing a lot
of scientific information,
but many clinical insights.
By 2002,
it was no longer possible
for a single author to write
on the subject of vitreous,
and thus the subject
of the rapport
de la Societe Francaise
d'Ophtalmologie
was Pathologie du vitre
and this multi-authored text
was 493 pages long,
indicating the expansion
of knowledge
both in scientific
and clinical domains.
Last year, the most recent
contribution to this field
was a 956-page treatise
that was co-authored
by 90 individuals
from all over the world,
covering subjects from a very
scientific perspective
to many clinical applications
of the basic science knowledge
that's been garnered
over the past several decades.
This tremendous increase
in knowledge in vitreous
has enabled
a greater appreciation
of the role of vitreous
in blinding disorders .
And I hope today's lecture
will give you
some insight
into this knowledge,
and also an eye to the future
at where we are headed.
